Triple negative breast cancer (TNBC) represents 15–20 % of all breast cancers that lack estrogen receptor (ER) and progesterone receptor (PgR) expression as well as amplification of the human epidermal growth factor receptor 2 (HER2). Here, ESR1 is linked to breast carcinoma.